Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating lenalidomide and dexamethasone with or without anakinra in early-stage multiple myeloma; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Anakinra (anakinra)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Indolent Plasma Cell Myeloma, Plasma Cell Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2020-03-25